Difference between revisions of "Andrew Philip Witty"
Jump to navigation
Jump to search
m |
|||
Line 1: | Line 1: | ||
{{person | {{person | ||
− | |wikipedia= | + | |wikipedia=https://en.wikipedia.org/wiki/Andrew_Witty |
|residence=UK | |residence=UK | ||
|companieshouse=https://beta.companieshouse.gov.uk/officers/uFGmA0Cu3MOW-amtHcftGj6jlLo/appointments | |companieshouse=https://beta.companieshouse.gov.uk/officers/uFGmA0Cu3MOW-amtHcftGj6jlLo/appointments | ||
Line 7: | Line 7: | ||
|image_caption=At [[Chatham House]] in 2015 | |image_caption=At [[Chatham House]] in 2015 | ||
|nationality=UK | |nationality=UK | ||
− | |birth_date= | + | |birth_date=A22 ugust 1964 |
− | |birth_place= | + | |birth_place=UK |
|death_date= | |death_date= | ||
|death_place= | |death_place= |
Revision as of 02:23, 29 August 2021
Andrew Philip Witty (businessman) | |
---|---|
At Chatham House in 2015 | |
Born | A22 ugust 1964 UK |
Residence | UK |
Nationality | UK |
Sir Andrew Philip Witty is a big pharma executive involved in organising the response to COVID-19.
Contents
Activities
In April 2020, Witty began a leave of absence from Optum to assist the WHO in developing a vaccination for COVID-19.
Statements
- In 2013 he reported he was "absolutely committed to rooting out corruption".[1]
Awards
Witty was knighted in the 2012 New Year Honours for services to the economy and the UK pharmaceutical industry.
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.